ClinicalTrials.gov
public full text
Public Domain
Safety and Efficacy of APD811 in Pulmonary Arterial Hypertension
The study was conducted as a placebo-controlled, randomized, 22-week double-blind study which included a dose titration period. An additional transition period occurred for those patients who elected to enroll into the open-label extension study, APD811-007. A total of 61 patients with PAH were enrolled.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Drug Therapy and Surgery in Congenital Heart Disease With Pulmonary Hypertension#1057025
- Comparison of Sequential to Initial Combination Therapy in PAH#904597
- TReatment of Pulmonary Hypertension Group II Study#123602
- A Trial of "APL-9796'' in Adults With Pulmonary Hypertension#307370
- Hydroxyurea in Pulmonary Arterial Hypertension#18729
Record · ID 1072107
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive